Hemagglutination and hemagglutination inhibition of turkey red blood cells with Mycoplasma hyopneumoniae

The ability of Mycoplasma hyopneumoniae to agglutinate RBC was evaluated to develop an in vitro cytadsorption assay. Using swine RBC in a microtitration hemagglutination test, no agglutination or partial agglutination was detected. Comparison of RBC from various other species indicated that improved hemagglutination was obtained with RBC from turkeys. This hemagglutination was detected only when mycoplasma cells used in the assay had been frozen and thawed, heated at 50 C for 30 minutes, or treated with trypsin. Treatment of RBC with trypsin or neuraminidase enhanced hemagglutination. Possible surface lectin activity in M hyopneumoniae was evaluated by use of carbohydrates in a blocking assay; hemagglutination was not inhibited by any of 13 carbohydrates evaluated. Mycoplasma hyopneumoniae convalescent porcine serum and monoclonal antibodies against 2 M hyopneumoniae immunogens of molecular weights of 64,000 and 41,000 inhibited hemagglutination.     

Mucus synthesis in the goblet cells of the small intestine in experimental infection with the coccidium Isospora suis in piglets

The state of mucus synthesis in the goblet cells of the small intestine was studied in conventional piglets infected with a dose of 200,000 oocytes of the coccidium Isospora suis the first and fifth day after parturition. The synthesis of mucus and its chemical characteristics undergo significant changes during the third and fourth day after infection. The activity of acid and neutral mucous substances declines; their level and the physiological synthetic function of goblet cells begin to return to the normal during the period starting on the eight to tenth day after infection. However, there were no fully functioning goblet cells in the broken numerical ratio even at the end of the period of investigation, i.e. the 13th day after infection. The thin surface layer of mucus remained almost unchanged within the whole extent of the small intestine parts studied.     

普通番茄与秘鲁番茄杂种后代的形态,亲和性及抗性表现

继获得普通番茄‘北京早红’与秘鲁番茄杂交种后,本试验着重于对杂种后代的形态、亲和性及抗性表现的观察,杂种的多数性状为双亲中的显性性状或双亲的中间型,但也表现了一些奇异性状,如果实的颜色和花序的形状与排列通过株间的“杂交”克服了杂种的高度自交不亲和性,从而顺利得到杂种的自交后代;杂种各世代均高抗TMV 0株系和1株系,并有部分选系抗TMV 1·2株系,由此判断秘鲁番茄亲本可能具有TM~a_2基因;用南京地区CMV厥叶株系和强株系分别接种,各世代表现部分抗病或耐病。     

Oesophagogastric parakeratosis in the growing pig: effects of the physical form of barley-based diets and added fibre

In four experiments a total of 288 individually fed pigs were given barley-based diets for about 100 days from about 20 kg liveweight. Fine grinding of barley increased the number and severity of oesophagogastric lesions. Pelleting a diet based on coarsely ground barley had a similar effect. Coarser grinding of the barley and substituting small proportions of oat husk, but not of bran, gave lower incidences and severities of lesions. The performance responses of the pigs differed and give a framework for deciding on the balance to be struck between optimal performance and the risk of lesion development.     

规模猪场母猪繁殖障碍综合征的病因调查

作者采用9套试剂盒，检测了7种能引起猪繁殖障碍综合征的传染病，对来自有繁殖障碍症状的305场次进行猪瘟(HC)抗原检测，并对包括这305场次在内的978个猪场(次)病例的6346份血清样品及52698份田间血清样品进行HC、猪繁殖与呼吸综合征(PRRS)、伪狂犬病(PR)、日本乙型脑炎(JE)、细小病毒感染(DPV)、猪衣原体病(Chla)、布鲁氏菌病(Bruc)等7种传染病的抗体检测。结果表明，在有繁殖障碍症状的猪场，HC抗原检出率高达61．97％，并且在不使用疫苗的情况下，PR3RS、PR、JE、Chla和PPV的抗体阳性场分别为49．42％、34．29％、12．72％、31．71％、和48．08％。HC和：PR交叉感染率达23．81％；HC和：PRRS交叉感染率为9．52％，PR和PRRS交叉感染率高达59．65％；另外JE、PPV也同HC、PR、PRRS存在部分交叉感染。不使用疫苗的田间血清样品的PRRS、PR的抗体阳性率也高。HC与PRRS．PR、Chla、JE和PPV中的一种或几种混合感染可能是引起繁殖障碍造成严重损失的主要原因。加强综合防制，优化免疫程序、把握引种关、加强生物安全措施是防制猪繁殖障碍综合征的关键。     

2009年4月全国饲料生产形势分析

1全国总体概况 4月份，国内畜禽产品消费增加，禽类产品价格有所回升，饲料产量继续增长，水产饲料增长幅度尤为明显。根据对全国29个省（自治区、直辖市）167家饲料企业的调查显示，其总产量为270．4万t，同比上涨5．1％，环比上涨12．2％（表1）。     

生姜对鸡生长性能及血液生化指标的影响

用1日龄健康地方鸡300只按完全随机设计分成3个处理组,每组100只,分别饲喂添加新鲜生姜粉1％(处理2)、喹乙醇80mg/kg(处理3)、不添加生姜和喹乙醇,(处理1,对照组)的日 粮,观察至60日龄。添加生姜组的日增重、饲料增重比和成活率明显优于对照组(P<0.05)。血清 胆固醇含量较对照组和喹乙醇组均低,血清总蛋白含量较对照组和喹乙醇组略高。     

Muscarinic receptor subtypes in equine tracheal smooth muscle

Selective muscarinic receptor antagonists were used to identify muscarinic receptor subtypes in equine trachealis strips. The M₁ receptor antagonist pirenzepine (10^–7 mol/L to 3 × 10^–5 mol/L) and the M₃ receptor antagonist 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, 10^–9 mol/L to 3 × 10^–7 mol/L³) dose dependently inhibited the contractile responses to electrical field stimulation (EFS) and exogenous acetylcholine (ACh). Schild plots yielded a pA₂ value for pirenzepine vs ACh of 6.75 ± 0.09, which is consistent with the affinity for M₂ or M₃ receptors, and a pA₂ value for 4-DAMP vs ACh of 8.47 ± 0.09, which is in agreement with the affinity for M₃ receptors. The M₂ receptor antagonist gallamine (10^–5 mol/L and 10^–4 mol/L) did not affect the response of trachealis to exogenous ACh and low-frequency EFS (0.1–2 Hz) but decreased the responses to high-frequency EFS (4–16 Hz). These results suggest that the muscarinic receptors mediating contractions induced by ACh in equine tracheal smooth muscle are of the M₃ subtype. The lack of an increase in the response to EFS following gallamine suggests that functional prejunctional inhibitory M₂ receptors are not present on the cholinergic nerves innervating equine tracheal smooth muscle.     

Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs.

Recombinant canine granulocyte colony-stimulating factor (rcG-CSF) was administered to clinically normal dogs, cyclic-hematopoietic dogs, and dogs undergoing autologous bone marrow transplantation, to determine whether rcG-CSF could be used to stimulate WBC production and function in normal and neutropenic dogs. To the normal dogs, rcG-CSF was administered by SC injection at rates of 1 microgram/kg of body weight, q 12 h; 2 micrograms/kg, q 12 h; or 5 micrograms/kg, q 12 h. A significant dose-dependent increase in the WBC count resulted from the stimulation of bone marrow progenitor cells. The increased WBC count was characterized by mature neutrophilia and monocytosis. Neutrophil myeloperoxidase and phagocytic activity were normal in rcG-CSF-treated normal dogs, demonstrating the production of normal functional neutrophils in response to rcG-CSF treatment. Recombinant canine G-CSF prevented neutropenia and associated clinical signs but did not completely eliminate the cycling of neutrophils in cyclic-hematopoietic dogs when it was administered at rates of 1 microgram/kg, q 12 h, and 2.5 micrograms/kg, q 12 h. The time to bone marrow reconstitution was not decreased in dogs treated with rcG-CSF at a rate of 2.5 micrograms/kg, q 12 h, for 13 days following autologous bone marrow transplantation. On the basis of our findings, we suggest that treatment with rcG-CSF is an effective way to stimulate myelopoiesis in dogs, but that the dose of rcG-CSF required to stimulate WBC production will vary depending on the cause of neutropenia. Recombinant canine G-CSF should be useful in stimulating production and maintaining function of WBC for treatment of clinical diseases seen commonly in veterinary practice.